Laurent Humeau
Chief Tech/Sci/R&D Officer en INOVIO PHARMACEUTICALS, INC. .
Fortuna: 295 214 $ al 31/03/2024
Relaciones activas
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Niranjan Y. Sardesai | M | 56 |
Geneos Therapeutics, Inc.
 Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | 15 años |
| Jacqueline Shea | M | 58 | 5 años | |
| Simon Benito | M | 79 | 21 años | |
| Jay Shepard | M | 65 | 4 años | |
| Wendy Yarno | F | 69 | 7 años | |
| Joann Peters | F | - |
Geneos Therapeutics, Inc.
Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | 5 años |
| Ann Miller | M | 66 | 5 años | |
| David Weiner | M | 67 | 41 años | |
| Roger Dansey | M | 68 | 3 años | |
| Lota Zoth | F | 64 | 6 años | |
| Ted Ingemar Jakob Fjällman | M | 46 |
Geneos Therapeutics, Inc.
Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | 2 años |
| Cheryl Elder | F | - | - | |
| Stephen Kemmerrer | M | - | 17 años | |
| Sangwoo Lee | M | 52 |
Geneos Therapeutics, Inc.
Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | 4 años |
| Shawn D. Bridy | M | - | 6 años | |
| Thomas Hong | M | - | - | |
| Sang-Woo Lee | M | - |
Geneos Therapeutics, Inc.
Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | 3 años |
| Jeffrey Skolnik | M | - | 8 años | |
| Maggie Campbell | F | - | 18 años | |
| Shawn Tomasello | F | 65 |
Geneos Therapeutics, Inc.
Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | - |
| Mark C. Twyman | M | 63 | 6 años | |
| Michael Sumner | M | 59 | 2 años | |
| Omar Khalil | M | - |
Geneos Therapeutics, Inc.
Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | 1 años |
| Samuel Broder | M | 79 |
Geneos Therapeutics, Inc.
Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | - |
| Peter Kies | M | 60 | 22 años | |
| Robert L. Crotty | M | 50 | 3 años | |
| Jennie Willson | F | - | - |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| J. Kim | M | 55 | 13 años | |
| Nancy Wysenski | F | 66 | 2 años | |
| George Bickerstaff | M | 68 | 1 años | |
| Thomas S. Kim | M | - | 10 años | |
| Jessica C. Lee | F | - | 16 años | |
| Angel Cabrera | M | 56 | 8 años | |
| Avtar Dhillon | M | 62 | 18 años | |
| Morton Collins | M | 88 | 11 años | |
| David Liebowitz | M | - | - | |
| Mark Bagarazzi | M | 63 | 9 años | |
| Mammen P. Mammen | M | 60 | 2 años | |
| Jennifer Laux | F | - | 5 años | |
| Scott M. White | M | - | 4 años | |
| Ami Shah Brown | M | - | 11 años | |
| Paul Stead | M | - | - | |
| Ben Matone | M | - | - | |
| Zane Yang | M | - | 2 años | |
| Michael W. Cordera | M | - | - | |
| Kate Broderick | M | - | 15 años | |
| Asli Gevgilili | M | - | 2 años | |
| Gene Kim | M | - | 3 años |
Estadísticas
| País | Relaciones | % del total |
|---|---|---|
| Estados Unidos | 48 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Laurent Humeau
- Red Personal
